AzTrials
AzTrials

Meniscus TearROOT-PCLNCT06507241

Clinical and Instrumental Assessment of Meniscal ROOT Tears Treated Through Suture to the Posterior Cruciate Ligament

An observational study of Meniscus Tear and Meniscus Lesion, run by Istituto Ortopedico Rizzoli at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The menisci are crucial for knee stability and functionality. Composed of fibrocartilaginous structure, they have an anatomical and biomechanical arrangement that makes them essential for load transmission and the prevention of osteoarthritis. Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Meniscus Tear, Meniscus Lesion, Knee Injuries
How many people
59 participants
Where
1 siteItaly
Study dates
18 Oct 2024to Dec 2027
How long will I take part?
2 Years
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Patients will be recruited among all subjects with "ROOT" type meniscal lesions treated surgically with arthroscopic suturing to the posterior cruciate ligament (ROOT-PCL) from 1/1/2021 to 31/12/2025 at the Rizzoli Orthopedic Institute.

Who may be able to join

  • Age between 18 and 50 years at the time of surgery;
  • Male and female gender;
  • Patients undergoing surgical treatment for at least one year for "ROOT" type meniscal lesions using arthroscopic suturing to the posterior cruciate ligament;
  • Pre-operative MRI performed.

Who cannot join

  • Patients no longer reachable;
  • Patients who refuse consent to the study;
  • Previous meniscectomy before surgery;
  • Previous ligament injuries before surgery;
  • New traumatic injuries after surgery;
  • Advanced knee osteoarthritis (Outerbridge grade III-IV) at the time of surgery;
Show all 10Show fewer
  • Severe knee malalignment (> 5°) at the time of surgery;
  • Severe obesity (BMI > 35);
  • Lower limb conditions preventing full weight-bearing during evaluation;
  • Infection or hematological/rheumatic conditions at the time of evaluation.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Stefano Zaffagnini contact

0516366075

stefano.zaffagnini@ior.it

Italy1 site, 1 recruiting
  • IRCCS Istituto Ortopedico Rizzoli

    Bologna, 40136

    Stefano Zaffagnini, 0516366075, stefano.zaffagnini@ior.it

    Recruiting

Other trials in Italy

About this study

The menisci are crucial for knee stability and functionality. Composed of fibrocartilaginous structure, they have an anatomical and biomechanical arrangement that makes them essential for load transmission and the prevention of osteoarthritis. Meniscal root lesions, known as "ROOT tears," compromise their protective function on the cartilage, leading to increased contact pressures between the tibia and femur and, over time, the development of osteoarthritis. Early diagnosis of these lesions is difficult and often the first detection is incidental. The subsequent challenges are significant due to a lack of pre-operative planning. A possible solution is a surgical technique involving arthroscopic suture of the posterior meniscal root along with the posterior cruciate ligament. This procedure does not require pre-operative planning and is applicable even in cases of incidental diagnosis.

Medical subject headings
Knee Injuries

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. RMN

    The 3 Tesla MRI is the diagnostic test of choice used in common clinical practice to evaluate the healing of these lesions at 1 and 2 years of follow-up. The measured parameter is meniscal extrusion. The measurement is taken in millimeters at the coronal sections visualizing the medial collateral ligament, from the capsular margin of the body to the outer profile of the tibial plateau. The "ghost sign" and tibial plateau edema will also be looked for. The main limitation of MRI is related to the fact that it is performed non-weight-bearing, with the patient in a supine position.

    Measured: 24 months after surgery

Secondary outcomes (6)
  1. Weight-bearing ultrasound

    Weight-bearing ultrasound is a method not commonly used in clinical practice but extremely useful in evaluating meniscal extrusion under conditions close to physiology. The measurement is performed in a static position with the patient standing upright with full weight-bearing. Once again, meniscal extrusion is measured in millimeters in the coronal sections visualizing the medial collateral ligament, from the capsular margin of the body to the outer profile of the tibial plateau. The strength of this method lies in its ability to replicate the biomechanical stress phenomena affecting the menisci during common daily activities, with the potential to detect lesions that would otherwise remain silent in a non-weight-bearing MRI.

    Measured: 24 months after surgery

  2. Physical examination

    A comprehensive assessment will include palpation to identify classic tender points related to meniscal pathology at the anterior, middle, and posterior joint lines. The presence of pain and the patient's overall health status will then be noted.

    Measured: 24 months after surgery

  3. International Knee Documentation Committee (IKDC)

    The IKDC form evaluates knee function subjectively across three domains: Symptoms (including pain, stiffness, swelling, and locking), Sports and daily activities, and Current knee function compared to before injury. It consists of 10 questions focusing on symptoms, sports participation, daily activity difficulties, and current knee function. Scores range from 0 to 100, with higher scores indicating better knee health: excellent (80-100), good (60-80), fair (30-60), and poor (0-30).

    Measured: 24 months after surgery

  4. Lysholm Knee Score

    It's a validated measurement scale that assesses knee functionality through 8 items, allowing to establish the knee's condition in relation to the functional demands of daily life activities. This assessment tool is used to evaluate surgical outcomes in patients who have undergone knee ligamentous or meniscal injuries. The final score is derived from the sum of various scores obtained across different items, ranging from 0 to 100. Scores are categorized into subgroups: Excellent (95-100); Good (84-94); Fair (65-83); Poor (<64).

    Measured: 24 months after surgery

  5. VAS (Visual Analog Scale)

    It is a quantitative one-dimensional numerical scale for pain assessment with 10 points; the scale requires the patient to select the number that best describes the intensity of their pain from 0 to 10 at that specific moment. 0 indicates no pain, while 10 indicates the worst possible pain.

    Measured: 24 months after surgery

  6. Tegner Score

    It allows estimation of the level of motor activity of a subject with a score ranging from 0 to 10, where 0 represents 'disability' and 10 represents 'participation in competitive sports such as national or international-level soccer'. This score is widely used to define the level of motor activity in patients with knee disorders. In the study, the Tegner Score will be completed directly by the investigator through an interview with the patient.

    Measured: 24 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2024
  2. Study start18 Oct 2024
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
59 participants (estimated)
Target duration
2 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT06507241
Sponsor's protocol ID
ROOT-PCL
Acronym
ROOT-PCL
Status last verified
Nov 2025
First submitted
4 Jul 2024
Last updated
19 Nov 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Meniscus Tear and Meniscus Lesion, run by Istituto Ortopedico Rizzoli at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Stefano Zaffagnini (0516366075, stefano.zaffagnini@ior.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

RMN (time frame: 24 months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in